Showing results (311-320 of 368) with videos related to
Sort By:
Pageof 37
Mayo Clinic Proceedings|August 16, 2015
Have Treatment Studies of Depression Become Even Less Generalizable? A Review of the Inclusion and Exclusion Criteria Used in Placebo-Controlled Antidepressant Efficacy Trials Published During the Past 20 YearsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.Depression and Anxiety|February 11, 2011
Diagnosing social anxiety disorder in the presence of obesity: implications for a proposed change in DSM-5Kristy L Dalrymple, Janine Galione, Joshua Hrabosky, et al.Journal of Affective Disorders|November 8, 2015
Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labelingMark Zimmerman, Heather L Clark, Matthew D Multach, et al.Journal of Clinical Psychopharmacology|February 6, 2016
Symptom Severity and the Generalizability of Antidepressant Efficacy Trials: Changes During the Past 20 YearsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.Journal of Personality Assessment|November 15, 2021
Exploring the Optimal Factor Structure of the Five Facet Mindfulness Questionnaire: Associations Between Mindfulness Facets and Dimensions of PsychopathologyJoseph M Diehl, Craig Rodriguez-Seijas, Justine S Thompson, et al.Journal of Psychiatric Research|October 30, 2012
A new type of scale for determining remission from depression: the Remission from Depression QuestionnaireMark Zimmerman, Jennifer H Martinez, Naureen Attiullah, et al.Comprehensive Psychiatry|February 8, 2011
Impact of obesity on the psychometric properties of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for major depressive disorderMark Zimmerman, Joshua I Hrabosky, Caren Francione, et al.The Journal of Clinical Psychiatry|May 10, 2012
Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission?Mark Zimmerman, Jennifer A Martinez, Naureen Attiullah, et al.The Journal of Clinical Psychiatry|April 23, 2010
Underrecognition of clinically significant side effects in depressed outpatientsMark Zimmerman, Janine N Galione, Naureen Attiullah, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|August 3, 2011
Depressed patients' perspectives of 2 measures of outcome: the Quick Inventory of Depressive Symptomatology (QIDS) and the Remission from Depression Questionnaire (RDQ)Mark Zimmerman, Janine N Galione, Naureen Attiullah, et al.Pageof 37